Concentra Group Holdings Parent, Inc.

NYSE•CON

CEO: Mr. William Keith Newton

Sector: Healthcare

Industry: Medical - Equipment & Services

Listing Date: 2010-05-25

Concentra Group Holdings Parent, Inc. provides occupational health services in the United States. The company offers occupational and consumer health services, including workers' compensation injury care, urgent care, clinical testing, preventative care, and employer services, as well as wellness programs through occupational health centers and onsite clinics. It also provides Concentra Telemed, a telemedicine solution for the treatment of work-related injuries and illnesses, and employer services; pharmacy solution under the Concentra Pharmacy name; and Concentra Medical Compliance Administration, a third-party administrator that helps to manage abuse testing programs for employers with regulated or non-regulated workforces. The company was founded in 1979 and is based in Mechanicsburg, Pennsylvania. Concentra Group Holdings Parent, Inc. is a subsidiary of Select Medical Corporation.

Contact Information

4714 Gettysburg Road, PO Box 2034, Mechanicsburg, PA, 17055, United States

717-972-1100

www.concentra.com

Market Cap

$3.01B

P/E (TTM)

17.7

37.9

Dividend Yield

1.1%

52W High

$24.69

52W Low

$18.55

52W Range

80%

Rank41Top 44.9%

4.0

F-Score

Modified Piotroski Analysis

Based on 4-year fundamentals

Average • 4 / 9 points

Scoring Range (0-9)

8-9: Excellent Value

6-7: Strong Fundamentals

4-5: Average Quality

0-3: Weak Performance

Data Period: 2022-2025

Financial Dashboard

Q4 2025 Data

Revenue

$539.10M-100.00%

4-Quarter Trend

EPS

$0.29+70.59%

4-Quarter Trend

FCF

$180.86M+0.00%

4-Quarter Trend

2025 Annual Earnings Highlights

Key Highlights

Revenue Growth Driven by Acquisitions Revenue reached $2.16B USD, marking a strong 13.9% increase year-over-year, driven by acquisitions completed in 2025.

Major Acquisitions Integrated Completed Nova ($265.0M) and Pivot Onsite ($54.4M) acquisitions, significantly boosting overall patient visit volume across segments.

EBITDA Margin Improvement Adjusted EBITDA margin improved to 20.0% due to increased volume and staffing efficiencies realized across occupational health centers.

Strong Liquidity Position Repurchased $22.4M common stock; Revolving Credit Facility balance zeroed out following $85M voluntary repayment by year-end.

Risk Factors

Labor Cost and Shortage Risks Labor shortages, increased turnover, and union activity could cause significant operating cost increases and reduce overall profitability.

Regulatory and Compliance Burden Conducting business in a heavily regulated industry faces risks from new interpretations, sanctions, and increased compliance costs.

Reimbursement Rate Constraints State fee schedules and cost containment initiatives may constrain ability to match cost inflation with necessary reimbursement rate increases.

Cybersecurity Breach Exposure Failure of IT systems via cyber-attack may compromise confidential patient data, resulting in potential legal and reputational harm.

Outlook

Focus on Organic Growth Strategy Strategy focuses on driving organic growth via market share capture and expanding through adjacent, mission-aligned acquisitions.

Expanding Service Offerings Continually evaluating expansion of onsite health clinics and telemedicine behavioral health services to meet evolving customer demand.

Debt Structure Management Term Loan balance of $931.2M remains, with derivative contracts hedging variable interest rate exposure through February 2028.

Share Repurchase Authorization $80.0M remains authorized for common stock repurchases under the program set to expire on December 31, 2027.

Peer Comparison

Revenue (TTM)

BHC

$10.31B

+7.1%

OGN

$6.22B

-2.9%

XRAY

$3.68B

-3.0%

Gross Margin (Latest Quarter)

BEAM

95.0%

-471.3pp

CPRX

90.8%

-2.1pp

NTLA

73.9%

-572.8pp

Key Metrics

Symbol	Market Cap	P/E (TTM)	ROE (TTM)	Debt to Assets
PBH	$3.32B	17.7	10.2%	30.9%
HAE	$3.07B	17.5	20.3%	49.2%
ITGR	$3.04B	29.4	6.0%	41.0%

Long-Term Trends

Last 4 Quarters

Revenue

Net Income

Operating Cash Flow

4Q Revenue CAGR

2.5%

Moderate Growth

4Q Net Income CAGR

-2.4%

Stable Profitability

Cash Flow Stability

100%

Strong Cash Flow

Deep Research

Next earnings:May 5, 2026

EPS:-

Revenue:-

Financials

Earnings Calls

Reports

News

Income Statement

Balance Sheet

Cash Flow Statement

Ratios

% Chg.

Income Statement	LTM

No Data